期刊文献+

舒尼替尼治疗恶性黑色素瘤1例

原文传递
导出
摘要 患者,女性,73岁。因肛门坠胀、大便变细、鲜血便半年,于2008年4月行结肠镜检查发现直肠占位。病理:直肠恶性黑色素瘤。5月行姑息手术+改道。术后未行放化疗。8月无诱因出现剧烈腹痛,腹部CT提示肝内多发低密度灶,肝周积液,考虑肝转移癌破裂出血。行介入肝内血管栓塞、止血等治疗。9月胸、腹部CT:双肺转移、双侧胸腔积液、
出处 《中国基层医药》 CAS 2010年第18期2592-2592,2595,共2页 Chinese Journal of Primary Medicine and Pharmacy
  • 相关文献

参考文献11

  • 1裴素丽,潘虎,马杰,乔思杰.肛管直肠恶性黑色素瘤临床病理误诊分析[J].中国胃肠外科杂志,2000,3(3):180-182. 被引量:13
  • 2Brady MS,Kavolius JP,Quan SH.Anorectal melanoma.A 64 year experience at Memorial Sloan Kettering Cancer Center.Dis Colon Rectum,1995,38 (2):146-151.
  • 3Roumen RM.Anorectal melanoma in the Netherlands:a report of 63 patients.Eur J Surg Oncol,1996,22,(6):598-601.
  • 4Falkson Cl,Ibrahim J,Kirkwood JM,et al.Phase Ⅲ trial of acarbazine versus dacarbazine with tamoxifen versus dacarbazine with interferon alfa-2b and tamoxifen in patients with metastatic malignant melanoma:an Eastern Cooperative Oncology Group study.Clin Oncol,1998,16 (5):1743 -1751.
  • 5Middleton M,Grob J,Aaronson N,et al.Randomized phase Ⅲ study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.J Clin 0ncol,2000,18(1):158-166.
  • 6Avril MF,Aamdal S,Grob JJ,et al.Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma:a phase Ⅲ study.Clin Onool,2004,15(22):1118-1125.
  • 7Bedikian AY,Millward M,Pehamberger H,et al.Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma:the Oblimersen Melanoma Study Group.J Clin Oncol,2006,24(29):4738-4745.
  • 8Mcdermott DF,Sosman FS,Hodi R,et al.Randomized phase Ⅱ Study of dacarbazine with or without sorafenib in patients with advanced Melanoma.Clin Oncol,2007,25(18):8511.
  • 9Mendel DB,Laird AD,Xin X,et al.In vivo antitumor activity of Sul1248,a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet derived growth factor receptors:Determination of a pharmacokinetic/pharmacodynamic relationship Clin Cancer Res,2003,9(1):327-337.
  • 10Abrams TJ,Lee LB,Murray LJ,et al.SU11248 inhibits KIT and platelet derived growth factor receptor beta in preclinical models of human small cell lung cancer.Mol Cancer Ther,2003,2(5):471-478.

二级参考文献8

  • 1Cagir B,Whiteford MH,Topham A,et al.Changing epidemiology of anorectal melanoma.Dis Colon Rectum,1999,42:1203-1208.
  • 2Grant-Kels JM,Bason ET,Grin CM.The misdiagnosis of malignant melanoma.J Am Acad Dermatol,1999,40:539-548.
  • 3Slingluff CJ,Vollmer RT,Seigler HF.Anorectal melanoma:clinical characteristics and results of surgical management in twenty-four patients.Surgery,1990,107:1-9.
  • 4吴咸中主编.腹都外科实践.北京:中国医药科技出版社,1990.670.
  • 5Delikaris P,Koutmeridis D,Tsonis G,et al.Synchronous anorectal malignant melanoma and rectal adenocarcinoma:report of a case.Dis Colon Rectum,1997,40:105-108.
  • 6Ben IO,Levy R,Weill S,et al.Anorectal malignant melanoma Aclinicopathologic study,including immunohistochemistry and DNA flow cytometry.Cancer,1997,79:18-25.
  • 7Bacchi CE,Bonetti F,Pea M,et al.HMB45.A review.Appl Immunohistochem,1996,4:73-85.
  • 8Achilles E,Schroder S.Positive cytokeratin results in malignant melanoma.Pitfall in differential immunohistological diagnosis of occult neoplasms.Pathology,1994,15:235-241.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部